Asari Ekpenyong

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Squamous Cell Carcinoma

Vascular Endothelial Growth Factor

Top Venues

Science advances

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Fanghui Chen, Chris Tang, Fan Yang, Asari Ekpenyong, Richard Qin, Jin Xie, Fatemeh Momen-Heravi, Nabil F Saba, Yong Teng
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances 10 (8) (2024)
Fanghui Chen, Chris Tang, Fan Yang, Asari Ekpenyong, Richard Qin, Jin Xie, Fatemeh Momen-Heravi, Nabil F Saba, Yong Teng
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances 10 (8) (2024)
Fanghui Chen, Chris Tang, Fan Yang, Asari Ekpenyong, Richard Qin, Jin Xie, Fatemeh Momen-Heravi, Nabil F Saba, Yong Teng
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances 10 (8) (2024)
Nabil F Saba, Ritu Chaudhary, Kedar S Kirtane, Angelo Marra, Asari Ekpenyong, Ashley Alesia McCook, Nicole C Schmitt, Jennifer H Gross, Mihir R Patel, Jill Remick, James E Bates, Mark W McDonald, Soumon F Rudra, William A Stokes, Maria I Poole, Xiaofei Song, Robbert J C Slebos, Yuan Liu, Conor E Steuer, Dong M Shin, Yong Teng, Christine H Chung
Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Fanghui Chen, Chris Tang, Fan Yang, Asari Ekpenyong, Richard Qin, Jin Xie, Fatemeh Momen-Heravi, Nabil F Saba, Yong Teng
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances 10 (8) (2024)
Fanghui Chen, Chris Tang, Fan Yang, Asari Ekpenyong, Richard Qin, Jin Xie, Fatemeh Momen-Heravi, Nabil F Saba, Yong Teng
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances 10 (8) (2024)
Fanghui Chen, Chris Tang, Fan Yang, Asari Ekpenyong, Richard Qin, Jin Xie, Fatemeh Momen-Heravi, Nabil F Saba, Yong Teng
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science advances 10 (8) (2024)
Nabil F Saba, Conor E Steuer, Asari Ekpenyong, Ashley Alesia McCook, Kelly Magliocca, Mihir Patel, Nicole C Schmitt, William A Stokes, James E Bates, Soumon Rudra, Jill Remick, Mark W McDonald, Marin Abousaud, Aik Choon Tan, Muhammad Zaki Hidayatullah Fadlullah, Ritu Chaudhary, Jameel Muzaffar, Kedar Kirtane, Yuan Liu, Georgia Z Chen, Dong M Shin, Yong Teng, Christine H Chung
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. Nature medicine (2024)
Nabil F Saba, Conor E Steuer, Asari Ekpenyong, Ashley Alesia McCook, Kelly Magliocca, Mihir Patel, Nicole C Schmitt, William A Stokes, James E Bates, Soumon Rudra, Jill Remick, Mark W McDonald, Marin Abousaud, Aik Choon Tan, Muhammad Zaki Hidayatullah Fadlullah, Ritu Chaudhary, Jameel Muzaffar, Kedar Kirtane, Yuan Liu, Georgia Z Chen, Dong M Shin, Yong Teng, Christine H Chung
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. Nature medicine (2024)
Nabil F Saba, Conor E Steuer, Asari Ekpenyong, Ashley Alesia McCook, Kelly Magliocca, Mihir Patel, Nicole C Schmitt, William A Stokes, James E Bates, Soumon Rudra, Jill Remick, Mark W McDonald, Marin Abousaud, Aik Choon Tan, Muhammad Zaki Hidayatullah Fadlullah, Ritu Chaudhary, Jameel Muzaffar, Kedar Kirtane, Yuan Liu, Georgia Z Chen, Dong M Shin, Yong Teng, Christine H Chung
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. Nature medicine (2023)